Literature DB >> 33293710

Oxford COVID-vaccine paper highlights lingering unknowns about results.

Heidi Ledford.   

Abstract

Entities:  

Keywords:  SARS-CoV-2; Vaccines

Mesh:

Substances:

Year:  2020        PMID: 33293710     DOI: 10.1038/d41586-020-03504-w

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  2 in total

1.  Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.

Authors:  Merryn Voysey; Sue Ann Costa Clemens; Shabir A Madhi; Lily Y Weckx; Pedro M Folegatti; Parvinder K Aley; Brian Angus; Vicky L Baillie; Shaun L Barnabas; Qasim E Bhorat; Sagida Bibi; Carmen Briner; Paola Cicconi; Andrea M Collins; Rachel Colin-Jones; Clare L Cutland; Thomas C Darton; Keertan Dheda; Christopher J A Duncan; Katherine R W Emary; Katie J Ewer; Lee Fairlie; Saul N Faust; Shuo Feng; Daniela M Ferreira; Adam Finn; Anna L Goodman; Catherine M Green; Christopher A Green; Paul T Heath; Catherine Hill; Helen Hill; Ian Hirsch; Susanne H C Hodgson; Alane Izu; Susan Jackson; Daniel Jenkin; Carina C D Joe; Simon Kerridge; Anthonet Koen; Gaurav Kwatra; Rajeka Lazarus; Alison M Lawrie; Alice Lelliott; Vincenzo Libri; Patrick J Lillie; Raburn Mallory; Ana V A Mendes; Eveline P Milan; Angela M Minassian; Alastair McGregor; Hazel Morrison; Yama F Mujadidi; Anusha Nana; Peter J O'Reilly; Sherman D Padayachee; Ana Pittella; Emma Plested; Katrina M Pollock; Maheshi N Ramasamy; Sarah Rhead; Alexandre V Schwarzbold; Nisha Singh; Andrew Smith; Rinn Song; Matthew D Snape; Eduardo Sprinz; Rebecca K Sutherland; Richard Tarrant; Emma C Thomson; M Estée Török; Mark Toshner; David P J Turner; Johan Vekemans; Tonya L Villafana; Marion E E Watson; Christopher J Williams; Alexander D Douglas; Adrian V S Hill; Teresa Lambe; Sarah C Gilbert; Andrew J Pollard
Journal:  Lancet       Date:  2020-12-08       Impact factor: 79.321

  2 in total
  9 in total

1.  COVID-19: vaccine's progress.

Authors:  Harald Brüssow
Journal:  Microb Biotechnol       Date:  2021-05-07       Impact factor: 6.575

Review 2.  Advances in the design and development of SARS-CoV-2 vaccines.

Authors:  Xue-Liang Peng; Ji-Si-Yu Cheng; Hai-Lun Gong; Meng-Di Yuan; Xiao-Hong Zhao; Zibiao Li; Dai-Xu Wei
Journal:  Mil Med Res       Date:  2021-12-16

3.  Pannexin-1 channel opening is critical for COVID-19 pathogenesis.

Authors:  Ross Luu; Silvana Valdebenito; Eliana Scemes; Antonio Cibelli; David C Spray; Maximiliano Rovegno; Juan Tichauer; Andrea Cottignies-Calamarte; Arielle Rosenberg; Calude Capron; Sandrine Belouzard; Jean Dubuisson; Djillali Annane; Geoffroy Lorin de la Grandmaison; Elisabeth Cramer-Bordé; Morgane Bomsel; Eliseo Eugenin
Journal:  iScience       Date:  2021-11-19

Review 4.  SARS-CoV-2: vaccinology and emerging therapeutics; challenges and future developments.

Authors:  Adedapo Adesokan; Mohammad A Obeid; Aisha F Lawal
Journal:  Ther Deliv       Date:  2022-02-23

5.  Analyzing the vaccination debate in social media data Pre- and Post-COVID-19 pandemic.

Authors:  Qingqing Chen; Andrew Crooks
Journal:  Int J Appl Earth Obs Geoinf       Date:  2022-05-05

Review 6.  Does COVID-19 Vaccination Warrant the Classical Principle "ofelein i mi vlaptin"?

Authors:  Michael Doulberis; Apostolis Papaefthymiou; Georgios Kotronis; Dimitra Gialamprinou; Elpidoforos S Soteriades; Anthony Kyriakopoulos; Eleftherios Chatzimichael; Kyriaki Kafafyllidou; Christos Liatsos; Ioannis Chatzistefanou; Paul Anagnostis; Vitalii Semenin; Smaragda Ntona; Ioanna Gkolia; Dimitrios David Papazoglou; Nikolaos Tsinonis; Spyros Papamichos; Hristos Kirbas; Petros Zikos; Dionisios Niafas; Jannis Kountouras
Journal:  Medicina (Kaunas)       Date:  2021-03-09       Impact factor: 2.430

7.  Workforce geography of older dermatologists during the COVID-19 pandemic.

Authors:  David X Zheng; Tarun K Jella; Melissa A Levoska; Anne Y Ning; Christopher R Cullison; Bryan T Carroll; Jeffrey F Scott
Journal:  Dermatol Ther       Date:  2021-03-06       Impact factor: 3.858

Review 8.  Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective.

Authors:  Colin D Funk; Craig Laferrière; Ali Ardakani
Journal:  Viruses       Date:  2021-03-05       Impact factor: 5.048

Review 9.  Developmental Landscape of Potential Vaccine Candidates Based on Viral Vector for Prophylaxis of COVID-19.

Authors:  Rajashri Bezbaruah; Pobitra Borah; Bibhuti Bhushan Kakoti; Nizar A Al-Shar'I; Balakumar Chandrasekaran; Da'san M M Jaradat; Munir A Al-Zeer; Saeid Abu-Romman
Journal:  Front Mol Biosci       Date:  2021-04-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.